01 · Explanation
Regression, accessibility, and release signoff
Objective: Assemble risk-based regression and accessibility evidence into a transparent release recommendation with defects, gaps, ownership, and rollback readiness.
Regression selection should follow change impact, dependency paths, defect history, critical customer journeys, permissions, data integrity, and operational controls. Maintain a small smoke set for rapid confidence and deeper suites for affected risks. Remove or repair flaky tests rather than treating reruns as normal evidence. Accessibility belongs throughout design and testing; combine automated checks with keyboard, zoom, focus, name-role-value, error, contrast, reflow, screen-reader, caption, and content review appropriate to the product. Automated tools find only part of accessibility risk, and conformance claims require qualified evaluation beyond this course.
A release recommendation summarizes build, scope, environments, results, open defects, critical criteria, accessibility findings, security or performance evidence, untested areas, data or migration checks, monitoring, support readiness, rollback, and named risk owners. QA recommends based on evidence; authorized stakeholders accept or reject residual risk. A signoff should never say 'bug-free.' If a critical criterion failed or required evidence is missing, state that clearly and recommend no release unless an authorized exception process applies. Preserve the test package and decision version so incidents can be compared with what was known at release time.
Before you begin
- Confirm F01, F02, F07-F09, F11, and F12; record that controlled test assets, requirement versions, environment details, accessibility evidence, tax baseline, defect links, execution records, and release authorization are absent.
- STOP. If controlled assets, versions, environments, accessibility evidence, tax baseline, defect links, or execution records are missing or conflict with F01/F02/F07–F09/F11/F12, route the manifest to authorized release, product, accessibility, payments, and dependency owners; do not claim regression execution, release recommendation approval, or authorization.

